agilon health, inc. Repayments of Long-Term Debt
agilon health, inc. (AGL) reported Repayments of Long-Term Debt of $3.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-05
- agilon health, inc. repayments of long-term debt for the quarter ending 2026-06-30 was $0.00.
- agilon health, inc. repayments of long-term debt for the quarter ending 2026-03-31 was $3.50M.
- agilon health, inc. repayments of long-term debt for the quarter ending 2025-12-31 was $0.00.
- agilon health, inc. repayments of long-term debt for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- agilon health, inc. repayments of long-term debt for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- agilon health, inc. repayments of long-term debt for fiscal 2024 was $3.75M, a 25.00% decline from fiscal 2023.
- agilon health, inc. repayments of long-term debt for fiscal 2023 was $5.00M, a 0.00% change from fiscal 2022.
- agilon health, inc. repayments of long-term debt for fiscal 2022 was $5.00M, a 95.83% decline from fiscal 2021.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $3.50M 10-Q · filed 2026-08-05 | $3.50M derived: sum of 3 quarters · filed 2026-08-05 | $3.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.50M 10-Q · filed 2026-05-06 | $3.50M derived: sum of 2 quarters · filed 2026-05-06 | $3.50M derived: sum of 3 quarters · filed 2026-05-06 | $3.50M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $0.00 derived: sum of 2 quarters · filed 2026-02-25 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $0.00 10-K · filed 2026-02-25 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $0.00 derived: sum of 2 quarters · filed 2026-08-05 | $0.00 10-Q · filed 2025-11-04 | $0.00 derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $0.00 10-Q · filed 2026-08-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-05 | $1.25M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-06 | $0.00 derived: sum of 2 quarters · filed 2026-05-06 | $1.25M derived: sum of 3 quarters · filed 2026-05-06 | $2.50M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $1.25M derived: sum of 2 quarters · filed 2026-02-25 | $2.50M derived: sum of 3 quarters · filed 2026-02-25 | $3.75M 10-K · filed 2026-02-25 |
| 2024-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.50M derived: sum of 2 quarters · filed 2025-11-04 | $3.75M 10-Q · filed 2025-11-04 | $5.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $2.50M 10-Q · filed 2025-08-04 | $3.75M derived: sum of 3 quarters · filed 2026-02-25 | $5.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.25M 10-Q · filed 2025-05-06 | $2.50M derived: sum of 2 quarters · filed 2026-02-25 | $3.75M derived: sum of 3 quarters · filed 2026-02-25 | $5.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $2.50M derived: sum of 2 quarters · filed 2026-02-25 | $3.75M derived: sum of 3 quarters · filed 2026-02-25 | $5.00M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.50M derived: sum of 2 quarters · filed 2024-11-07 | $3.75M 10-Q · filed 2024-11-07 | $5.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $2.50M 10-Q · filed 2024-08-06 | $3.75M derived: sum of 3 quarters · filed 2025-02-25 | $5.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $1.25M 10-Q · filed 2024-05-07 | $2.50M derived: sum of 2 quarters · filed 2025-02-25 | $3.75M derived: sum of 3 quarters · filed 2025-02-25 | $5.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $2.50M derived: sum of 2 quarters · filed 2025-02-25 | $3.75M derived: sum of 3 quarters · filed 2025-02-25 | $5.00M 10-K · filed 2025-02-25 |
| 2022-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.50M derived: sum of 2 quarters · filed 2023-11-02 | $3.75M 10-Q · filed 2023-11-02 | $5.00M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $2.50M 10-Q · filed 2023-08-03 | $3.75M derived: sum of 3 quarters · filed 2024-02-27 | $3.75M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $1.25M 10-Q · filed 2023-05-09 | $2.50M derived: sum of 2 quarters · filed 2024-02-27 | $2.50M derived: sum of 3 quarters · filed 2024-02-27 | $52.50M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $1.25M derived: sum of 2 quarters · filed 2024-02-27 | $51.25M derived: sum of 3 quarters · filed 2024-02-27 | $119.90M 10-K · filed 2024-02-27 |
| 2021-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $50.00M derived: sum of 2 quarters · filed 2022-11-03 | $118.65M 10-Q · filed 2022-11-03 | $119.41M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $118.65M 10-Q · filed 2022-08-04 | $119.41M derived: sum of 3 quarters · filed 2023-03-01 | $120.17M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $68.65M 10-Q · filed 2022-05-05 | $69.41M derived: sum of 2 quarters · filed 2023-03-01 | $70.17M derived: sum of 3 quarters · filed 2023-03-01 | $70.93M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | $760.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $1.52M derived: sum of 2 quarters · filed 2023-03-01 | $2.28M derived: sum of 3 quarters · filed 2023-03-01 | $3.04M 10-K · filed 2023-03-01 |
| 2020-09-30 | $761.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28 | $1.52M derived: sum of 2 quarters · filed 2021-10-28 | $2.28M 10-Q · filed 2021-10-28 | |
| 2020-06-30 | $760.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $1.52M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $760.00K 10-Q · filed 2021-05-26 | |||
| 2019-12-31 | $3.59M 10-K · filed 2022-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |